75 related articles for article (PubMed ID: 554643)
1. [Antithrombin III assay using a chromogenic substrate in newborns].
De Mattia D; Montagna O; Marvulli E
Boll Soc Ital Biol Sper; 1979 Apr; 55(8):746-50. PubMed ID: 554643
[TBL] [Abstract][Full Text] [Related]
2. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
[No Abstract] [Full Text] [Related]
3. [Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer].
Hopmeier P; Heuss F; Fischer M
Wien Klin Wochenschr; 1984 Dec; 96(24):881-4. PubMed ID: 6528618
[TBL] [Abstract][Full Text] [Related]
4. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
Koresawa S; Matsuda N; Ueda S
Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
[No Abstract] [Full Text] [Related]
5. [The determination of inhibitors of haemostasis using chromogenic substances (author's transl)].
Jürgens H; von Voss H; Göbel U
Klin Padiatr; 1980 Jul; 192(4):330-5. PubMed ID: 7192767
[TBL] [Abstract][Full Text] [Related]
6. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
van Voorthuizen H; Kluft C
Thromb Haemost; 1984 Dec; 52(3):350-3. PubMed ID: 6531759
[TBL] [Abstract][Full Text] [Related]
7. Determination of the biological activity of heparin by use of a chromogenic substrate.
Bartl K; Dorsch E; Lill H; Ziegenhorn J
Thromb Haemost; 1980 Feb; 42(5):1446-51. PubMed ID: 7368151
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
[No Abstract] [Full Text] [Related]
9. [Dynamic investigation of antithrombin III in the plasma of patients with acute myocardial infarction].
Zhu JZ; Chen SL; Cui ZC
Zhonghua Nei Ke Za Zhi; 1991 Dec; 30(12):746-8, 789. PubMed ID: 1815877
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.
De Stefano V; Leone G; De Carolis MP; Ferrelli R; De Carolis S; Pagano L; Tortorolo G; Bizzi B
Thromb Haemost; 1987 Jun; 57(3):329-31. PubMed ID: 3660333
[TBL] [Abstract][Full Text] [Related]
11. [On the determination of plasma antithrombin III with chromogenic peptide substrate (author's transl)].
Nakamura S; Takizawa N; Nakanishi K; Igarashi M
Rinsho Byori; 1980 Jan; 28(1):81-6. PubMed ID: 7373880
[No Abstract] [Full Text] [Related]
12. Chromogenic peptide substrate assays in patients with multiple trauma.
Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
14. [Levels of antithrombin III and proteins C in the newborn infant].
Abad A; Marco Vera P; Mompel A; García Pérez A
Sangre (Barc); 1989 Apr; 34(2):91-5. PubMed ID: 2756455
[TBL] [Abstract][Full Text] [Related]
15. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
[TBL] [Abstract][Full Text] [Related]
16. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
Campo G; Modena N; Gallo A; Ciaffoni S
Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
Asai K; Takagi A; Otsubo M
Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
[No Abstract] [Full Text] [Related]
18. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
Asai K; Asai M
Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
[TBL] [Abstract][Full Text] [Related]
19. Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays.
Smith-Erichsen N; Aasen AO; Amundsen E
Acta Chir Scand Suppl; 1982; 509():33-8. PubMed ID: 6187146
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and functional study of antithrombin III in newborn infants.
McDonald MM; Hathaway WE; Reeve EB; Leonard BD
Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
